Clinical trials
Pigmentation Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 8 |
| Recruiting | 7 |
| Withdrawn | 2 |
| Terminated | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NovoBliss Research Pvt Ltd | 3 |
| Syneron Medical | 3 |
| University of California, Davis | 3 |
| Centre Hospitalier Universitaire de Nice | 2 |
| Chulalongkorn University | 2 |
| Cutera Inc. | 2 |
| Emory University | 2 |
| Integrative Skin Science and Research | 2 |
| Netherlands Institute for Pigment Disorders | 2 |
| University of California, San Francisco | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pigmentation Disorders | 56 |
| Vitiligo | 7 |
| Melanosis | 6 |
| Hyperpigmentation | 5 |
| Hypopigmentation | 5 |
| Skin Diseases | 5 |
| Hypoxia | 4 |
| Erythema | 3 |
| Cicatrix | 2 |
| Alopecia | 1 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.